{{Rsnum
|rsid=1709084
|Gene=CYP2A13
|Chromosome=19
|position=41096565
|Orientation=plus
|GMAF=0.1162
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYP2A13
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 83.2 | 15.9 | 0.9
| HCB | 97.8 | 2.2 | 0.0
| JPT | 95.6 | 4.4 | 0.0
| YRI | 58.5 | 36.7 | 4.8
| ASW | 56.1 | 42.1 | 1.8
| CHB | 97.8 | 2.2 | 0.0
| CHD | 96.3 | 3.7 | 0.0
| GIH | 75.2 | 24.8 | 0.0
| LWK | 60.0 | 39.1 | 0.9
| MEX | 69.0 | 27.6 | 3.4
| MKK | 73.1 | 19.9 | 7.1
| TSI | 86.3 | 13.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19414505
|Title=CYP 450 polymorphisms as risk factors for early onset lung cancer: gender specific differences
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}